GCN-5/PGC-1α signaling is activated and associated with metabolism in cyclin E1-driven ovarian cancer ( vol 11 pg 4890 , 2019)

被引：0
|
作者：
Guo, Ting [1 ]
Li, Bin [1 ]
Gu, Chao [1 ]
Chen, Xiuying [1 ]
Han, Mengxin [1 ]
Liu, Xiaocheng [1 ]
Xu, Congjian [1 ]
机构：
[1] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China
来源：
AGING-US | 2024年 / 16卷 / 10期
关键词：
high grade serous ovarian cancer; CCNE1; glucose metabolism;
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：9303 / 9304
页数：2
相关论文
共 32 条
  • [21] Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades (vol 11,813,2019)
    Siu, Michelle K. Y.
    Jiang, Yu-Xin
    Wang, Jing-Jing
    Leung, Thomas H. Y.
    Han, Chae Young
    Tsang, Benjamin K.
    Cheung, Annie N. Y.
    Ngan, Hextan Y. S.
    Chan, Karen K. L.
    CANCERS, 2024, 16 (21)
  • [22] Combination Treatment with an Antibody-Drug Conjugate (A1mcMMAF) Targeting the Oncofetal Glycoprotein 5T4 and Carboplatin Improves Survival in a Xenograft Model of Ovarian Cancer (vol 14, pg 465, 2019)
    Wan, Y. Louise
    Sapra, Puja
    Bolton, James
    Chua, Jia Xin
    Durrant, Lindy G.
    Stern, Peter L.
    TARGETED ONCOLOGY, 2019, 14 (06) : 769 - 769
  • [23] LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway (vol 38, 418, 2019)
    Qiao, Kun
    Ning, Shipeng
    Wan, Lin
    Wu, Hao
    Wang, Qin
    Zhang, Xingda
    Xu, Shouping
    Pang, Da
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)
  • [24] RETRACTION: Analgesic effects of microRNA-129-5p against bone cancer pain through the EphB1/EphrinB2 signaling pathway in mice (Retraction of Vol 120, Pg 2876, 2019)
    Yu, Shao-Nan
    Liu, Gui-Feng
    Li, Long-Yun
    Zhao, Guo-Qing
    Liu, Lin
    Li, Xue-Feng
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S103 - S103
  • [25] RETRACTION: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retraction of Vol 12, Pg 9999, 2020)
    Wang, Y.
    Wang, X.
    Han, L.
    Hu, D.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3457 - 3457
  • [26] RETRACTION: FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway (Retraction of Vol 11, Pg 1427, 2019)
    Ni, Wei
    Xia, Yaoxiong
    Bi, Yuxu
    Wen, Fan
    Hu, Dong
    Luo, Lin
    AGING-US, 2023, 15 (07): : 2812 - 2812
  • [27] RETRACTION: Long noncoding RNA H19 regulates HIF-1α/AXL signaling through inhibiting miR-20b-5p in endometrial cancer (Retraction of Vol 18, Pg 2454, 2019)
    Zhu, He
    Jin, Yue-Mei
    Lyu, Xue-Man
    Fan, Li-Mei
    Wu, Fei
    CELL CYCLE, 2021, 20 (24) : 2663 - 2663
  • [28] RETRACTION: Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway (Retraction of Vol 17, art no 190, 2019)
    Dai, Jun
    Wei, Rujia
    Zhang, Peihai
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [29] RETRACTION: microRNA-542-5p protects against acute lung injury in mice with severe acute pancreatitis by suppressing the mitogen-activated protein kinase signaling pathway through the negative regulation of P21-activated kinase 1 (Retraction of Vol 120, Pg 290, 2019)
    Wu, Xing-Mao
    Ji, Kai-Qiang
    Wang, Hai-Yuan
    Zhao, Yang
    Jia, Jia
    Gao, Xiao-Peng
    Zang, Bin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 : S117 - S117
  • [30] RETRACTED: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retracted article. See vol. 14, pg. 3457, 2022)
    Wang, Yuqin
    Wang, Xiuying
    Han, Liwei
    Hu, Dongdong
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 9999 - 10010
1234